Evidence map›Paper›PMID 28223969›Full record

ArticleFrontiers in microbiology2017

Brina Portugal, Flávia N Motta, Andre F Correa, Diego O Nolasco, Hugo de Almeida, Kelly G Magalhães, Ana L V Atta, Francisco D Vieira, Izabela M D Bastos, Jaime M Santana

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Prolyl Oligopeptidase FromFrontiers in microbiology · 2020
    Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Brina PortugalPathogen-Host Interface Laboratory, Department of Cell Biology, The University of Brasília, Brasília Brazil.
Flávia N MottaPathogen-Host Interface Laboratory, Department of Cell Biology, The University of Brasília, BrasíliaBrazil; Instituto de Patologia Tropical e Saúde Pública, Universidade Federal de GoiásGoiânia, Brazil.
Andre F CorreaPathogen-Host Interface Laboratory, Department of Cell Biology, The University of Brasília, BrasíliaBrazil; Instituto de Patologia Tropical e Saúde Pública, Universidade Federal de GoiásGoiânia, Brazil.
Diego O NolascoPhysics Course and Postgraduate Program in Genomic Sciences and Biotechnology, Catholic University of Brasília Brasília, Brazil.
Hugo de AlmeidaPathogen-Host Interface Laboratory, Department of Cell Biology, The University of Brasília, Brasília Brazil.
Kelly G MagalhãesLaboratory of Immunology and Inflammation, Department of Cell Biology, The University of Brasília Brasília, Brazil.
Ana L V AttaLaboratório Central de Saúde Pública do Distrito Federal Brasília, Brazil.
Francisco D VieiraLaboratório Central de Saúde Pública do Distrito Federal Brasília, Brazil.
Izabela M D BastosPathogen-Host Interface Laboratory, Department of Cell Biology, The University of Brasília, Brasília Brazil.
Jaime M SantanaPathogen-Host Interface Laboratory, Department of Cell Biology, The University of Brasília, Brasília Brazil.
Universidade de Brasília · BRGoverno do Distrito Federal · BRUniversidade Católica de Brasília · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tuberculosis (TB) is a disease that leads to death over 1 million people per year worldwide and the biological mediators of this pathology are poorly established, preventing the implementation of effective therapies to improve outcomes in TB. Host-bacterium interaction is a key step to TB establishment and the proteases produced by these microorganisms seem to facilitate bacteria invasion, migration and host immune response evasion. We presented, for the first time, the identification, biochemical characterization, molecular dynamics (MDs) and immunomodulatory properties of a prolyl oligopeptidase (POP) from

Indexed as

fluorescence spectroscopymolecular dynamicMycobacterium tuberculosis proteaseproinflammatory cytokinesprolyl oligopeptidaseserine proteasetuberculosis

Identifiers

PMID28223969
PMCPMC5293833
OpenAlexW2586205336

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.